Aelis Farma SA (EPA:AELIS)
1.204
+0.004 (0.33%)
Jun 5, 2026, 12:23 PM CET
Aelis Farma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.21 | 14.05 | 20.23 | 34.4 | 24.71 |
Short-Term Investments | 0.5 | - | - | - | - |
Cash & Short-Term Investments | 8.71 | 14.05 | 20.23 | 34.4 | 24.71 |
Cash Growth | -38.03% | -30.54% | -41.19% | 39.20% | 444.51% |
Accounts Receivable | 0.04 | 0.47 | 1.76 | 1.08 | - |
Other Receivables | 0.92 | 2 | 1.76 | 2.69 | 1.61 |
Receivables | 0.96 | 2.46 | 3.52 | 3.77 | 1.61 |
Inventory | - | - | 0.05 | 0.04 | 0.02 |
Prepaid Expenses | 0.33 | 0.61 | 0.93 | 0.31 | 1.61 |
Other Current Assets | 0.3 | 1.01 | 0.14 | 0.09 | 0.08 |
Total Current Assets | 10.29 | 18.13 | 24.87 | 38.6 | 28.03 |
Property, Plant & Equipment | 1.09 | 1.34 | 1.18 | 0.18 | 0.2 |
Other Intangible Assets | 0.19 | 0.19 | 0.19 | 0.19 | 0.09 |
Other Long-Term Assets | 0.48 | 0.05 | 0.04 | 0.25 | - |
Total Assets | 12.05 | 19.71 | 26.28 | 39.22 | 28.31 |
Accounts Payable | 0.51 | 1.18 | 4.5 | 2.42 | 2.24 |
Accrued Expenses | 0.23 | 0.79 | 0.65 | 0.58 | - |
Short-Term Debt | - | - | 0.02 | - | - |
Current Portion of Long-Term Debt | 1.26 | 1.31 | 0.96 | 0.81 | 1.14 |
Current Portion of Leases | 0.18 | 0.17 | 0.11 | 0.01 | 0.02 |
Current Income Taxes Payable | 0.03 | 0.08 | 0.13 | 0.08 | 0.47 |
Current Unearned Revenue | 0.14 | 0.96 | 3.67 | 11.88 | 10.35 |
Other Current Liabilities | - | 0.32 | 0 | 0 | - |
Total Current Liabilities | 2.34 | 4.81 | 10.03 | 15.78 | 14.22 |
Long-Term Debt | 4.41 | 3.69 | 2.05 | 3.01 | 6.76 |
Long-Term Leases | 0.76 | 0.92 | 0.9 | - | - |
Long-Term Unearned Revenue | - | 0.04 | - | 0.58 | 6.34 |
Other Long-Term Liabilities | 0.1 | 0.14 | 0.1 | 0.06 | 0.1 |
Total Liabilities | 7.61 | 9.59 | 13.08 | 19.43 | 27.41 |
Common Stock | 0.14 | 0.14 | 0.13 | 0.05 | 0 |
Additional Paid-In Capital | 16.01 | 23.74 | - | - | - |
Retained Earnings | -6.43 | -7.46 | - | - | - |
Treasury Stock | -1.3 | -1.36 | - | - | - |
Comprehensive Income & Other | -3.98 | -4.95 | 13.07 | 19.74 | 0.9 |
Shareholders' Equity | 4.44 | 10.12 | 13.2 | 19.79 | 0.9 |
Total Liabilities & Equity | 12.05 | 19.71 | 26.28 | 39.22 | 28.31 |
Total Debt | 6.61 | 6.08 | 4.04 | 3.82 | 7.92 |
Net Cash (Debt) | 2.1 | 7.97 | 16.19 | 30.57 | 16.79 |
Net Cash Growth | -73.60% | -50.79% | -47.04% | 82.06% | - |
Net Cash Per Share | 0.15 | 0.59 | 1.26 | 2.58 | 1.75 |
Filing Date Shares Outstanding | 13.6 | 13.59 | 13.18 | 12.6 | 9.59 |
Total Common Shares Outstanding | 13.6 | 13.59 | 13.18 | 12.6 | 9.59 |
Working Capital | 7.95 | 13.32 | 14.84 | 22.82 | 13.81 |
Book Value Per Share | 0.33 | 0.74 | 1.00 | 1.57 | 0.09 |
Tangible Book Value | 4.25 | 9.93 | 13.01 | 19.6 | 0.81 |
Tangible Book Value Per Share | 0.31 | 0.73 | 0.99 | 1.56 | 0.08 |